David Claveau

David Claveau is an experienced professional in the pharmaceutical and biotechnology industries, currently serving as Vice-President of Business Development for North America at Sygnature Discovery since January 2024. Prior to this role, David held the position of Senior Director of Business Development at NuChem Sciences, which was acquired by Sygnature Discovery, from April 2023 to February 2024. Additional experience includes serving as Associate Director of Business Intelligence at Ventus Therapeutics and Director of Medical Affairs at Avir Pharma Inc., where responsibilities included medical information and advisory roles. David has also held various positions at AstraZeneca, Almirall, and Merck, focusing on medical science liaison and professional relations in respiratory fields. David's academic background includes an M.Sc. in Biomedical Sciences from Université de Montréal and a B.Sc. in Biochemistry from Université Laval.